Merck’s outlook for 2026 comes in below expectations as pipeline faces make-or-break year

Published: Feb. 3, 2026 at 6:55 a.m. ET Merck on Tuesday revealed a lower-than-expected outlook for 2026…

Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation

Published: Jan. 7, 2026 at 12:36 p.m. ET Merck could lose up to $630 million in Gardasil…

Trump to announce new drug-pricing deals later today

Published: Dec. 19, 2025 at 10:45 a.m. ET The White House is getting ready to announce more…

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Published: Nov. 18, 2025 at 4:21 p.m. ET Biopharma is back, and it’s smarter, slimmer and more…

This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.

Dow’s banner day points to investor pivot beyond S&P 500’s top winners

Published: Nov. 11, 2025 at 4:28 p.m. ET The Dow Jones Industrial Average ended Tuesday’s session at…